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Patient awareness and concern regarding the potential health risks from ionizing radiation have peaked recently (Coakley et
al., 2011) following widespread press and media coverage of the projected cancer risks from the increasing use of computed
tomography (CT) (Berrington et al., 2007). The typical young and educated patient with inflammatory bowel disease (IBD) may
in particular be conscious of his/her exposure to ionising radiation as a result of diagnostic imaging. Cumulative eﬀective doses
(CEDs) in patients with IBD have been reported as being high and are rising, primarily due to the more widespread and repeated
use of CT (Desmond et al., 2008). Radiologists, technologists, and referring physicians have a responsibility to firstly counsel
their patients accurately regarding the actual risks of ionizing radiation exposure; secondly to limit the use of those imaging
modalities which involve ionising radiation to clinical situations where they are likely to change management; thirdly to ensure
that a diagnostic quality imaging examination is acquired with lowest possible radiation exposure. In this paper, we synopsize
available evidence related to radiation exposure and risk and we report advances in low-dose CT technology and examine the role
for alternative imaging modalities such as ultrasonography or magnetic resonance imaging which avoid radiation exposure.
1. Introduction
Increased exposure to ionising radiation in patients with
Crohn’s disease has been documented in recent publications
and is a significant cause for concern [1, 2]. Improvements
in CT hardware and software have greatly expanded its role
in the diagnosis and characterisation of IBD, the detection of
complications, and the assessment of response to treatment
[2]. These advances have been hugely beneficial to the
management of many patients, but CT may on occasion
become a victim of its own success when IBD patients may
undergo CT examination for a less than robust indication
and the radiologist’s report may not have any impact
upon patient management. In these cases, the potential for
carcinogenesis as a result of radiation exposure is diﬃcult to
justify.
2. Ionizing Radiation: Potential Hazards
in IBD Patient
Cancer induction is the primary concern for IBD patients
who are routinely exposed to ionizing radiation. IBD
patients can be subjected to serial imaging studies over
prolonged periods of followup due to early age of pre-
sentation and, sometimes, decades of active disease [2].
In addition, IBD patients are already at increased risk of
certain malignancies such as colorectal carcinoma and small
bowel adenocarcinoma and these risks could potentially be
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compounded in patients with more severe disease and by use
of immunomodulatory drugs.
Carcinogenesis is a stochastic eﬀect of X-radiation; that
is to say it is random. Cancer induction does not exhibit an
upper or lower threshold of occurrence, and the probability
of cancer induction is variable [3]. It is noteworthy that
there is no X-radiation dose where cancer induction may not
occur. Greater exposure to CT, however, is believed by many
to increase the likelihood of carcinogenesis in IBD patients,
but carcinogenesis typically occurs many years remote from
the exposure [4]. Similarly, exposure to ionizing radiation in
early life is believed to magnify the risk of tumour induction
[5]. It has been reported that patients who are diagnosed with
Crohn’s disease as children are more likely to receive higher
lifetime cumulative radiation exposures [2, 5, 6]. Children
undergoing CT receive greater organ doses than adults, and,
in children, most organs are more sensitive to radiation-
induced cancer than in adults [5]. Thus, particular care
needs to be taken in imaging of all Crohn’s disease patients,
particularly in those where the initial diagnosis was made as
a child.
3. Computed Tomography and Patient Dose
When an X-ray beam interacts within a patient, energy
is deposited in irradiated organs. The absorbed dose is a
measure of the amount of energy deposited per unit mass.
The eﬀective dose (ED), measured in Sieverts (Sv), is a more
useful unit that estimates the biologic detriment of a given
absorbed dose. ED takes into account each organ exposed to
ionizing radiation as well as each organ’s radiosensitivity [7].
CT exposures by their nature are not uniformly distributed
across the entire patient’s body but are limited to the region
of the patient’s body that is being examined, for example,
a patient’s head during a CT brain. One of the primary
benefits of ED as a unit is that it accounts for nonuniform
doses, such as to a patient’s head during CT brain, which are
subsequently expressed as equivalent whole-body dose that
would have the same risk of biologic eﬀect. ED, therefore,
allows more accurate comparison of the risk of biological
eﬀect between, for instance, a CT scan of brain and a CT scan
of abdomen and pelvis [8]. ED, as a unit, also allows us to
compare the risk of biologic eﬀect between ionizing radiation
doses delivered by diﬀerent imaging modalities such as CT
and nuclear medicine, plain radiography, and fluoroscopy.
A standard CT of abdomen and pelvis (CTAP) exposes
the patient to an ED of approximately 8mSv although
values reported in literature range widely from 3.5mSv to
25mSv [9]. The radiation exposure associated with CTAP
is substantial (8mSv) when compared to chest radiograph
(0.02mSv), plain radiograph of the abdomen (PFA) (0.7
mSv), and barium studies (3.5–5mSv) [9, 10].
4. Cumulative Radiation Exposure in
Inflammatory Bowel Disease
A 15-year retrospective examination of abdominal imaging
in a tertiary referral centre for Crohn’s disease reported
that subgroups of Crohn’s disease patients were “at risk”
for increased exposures to ionizing radiation [2]. The
subgroups who were at greater risk of higher cumulative
radiation exposure included patients in whom the diagnosis
of Crohn’s disease was made before 17 years of age, those
with more severe disease requiring treatment with steroids or
infliximab, and those requiring surgical intervention [2]. The
average cumulative eﬀective dosages per patient increased
over the 15-year study period from 7.9mSv in the initial 5-
year period to 25mSv in the final 5-year period [2]. This
escalation was mainly attributed to increased use of CT,
without a corresponding drop in the use of plain radiographs
of the abdomen. Of the imaging studies performed during
this period, 19.7% were CT scans, accounting for 84.7% of
the diagnostic radiation exposure [2]. A cumulative eﬀective
dose of greater than 75mSv, the eﬀective dose equivalent of
3,750 standard chest X-rays, was noted in almost 16% of
patients [2, 10]. Cumulative exposure to low-level ionising
radiation of this magnitude has previously been estimated to
increase mortality due to cancer by 7.3% [4].
5. Biologic Effects of Exposure to Ionizing
Radiation
Exposure to ionizing radiation results in DNA damage which
is intimately related to the appearance of gene or chromo-
somal mutations and therefore related to multistage cancer
development. The pathway of cancer induction secondary
to ionizing radiation exposure does not appear to diﬀer
from that which applies to spontaneous cancer or to cancers
associated with exposure to other carcinogens [11].
Acute high-level exposure to ionizing radiation produces
clearly meusurable consequences in humans, including can-
cer induction. In general, protracted exposures to the same
total dose of X-radiation are associated with lower risks
than those of an acute exposure, both for cancer and other
endpoints [12]. Latency of cancer induction due to ionizing
radiation exposure is well recognized, and available evidence
indicates that the time from exposure to incidence of cancer
for solid tumors is at least 5 years andmore commonly 10–20
years [13].
The Life Span Study of a cohort of atomic bomb sur-
vivors is the epidemiological study with the highest statistical
power for evaluating the eﬀect and risks of low-dose ionizing
radiation exposure [14]. Atomic bomb survivors with a
dose range from 5 to 100mSv (mean dose, 29mSv) show a
significantly increased incidence of solid cancer (P = 0.05)
compared with the population who were exposed to <5mSv
[15].
It has been estimated that 29 000 future cancers could be
related to CT scans performed in the US in 2007 [16] and
this risk may be three to five times higher for children [17].
6. What Can We Do?
The best way of protecting patients from the potentially
detrimental eﬀects of ionising radiation is to limit their
exposure to ionising radiation in every available way. CT
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has been reported to represent 10% of all studies using
ionising radiation, while accounting for two-thirds of the
overall radiation dose to patients [18]. The three principal
ways of reducing the overall radiation dose from CT in the
population include limiting the use of CT scanning to those
clinical scenarios where the examination is unequivocally
indicated and likely to change patient management, the use,
where feasible, of alternative imaging modalities such as
ultrasonography andMRI which do not result in exposure to
ionising radiation, and when CT is indicated, the use of low-
dose CT protocols, which utilise all available CT technology
developed for radiation dose optimisation, ensuring that a
diagnostic quality CT study is acquired at lowest possible
radiation exposure [19].
7. Low-Dose CT Technology
An emerging method of limiting radiation exposure in
populations requiring frequent imaging is development of
disease-specific low-dose CT protocols [20]. Low-dose CT
protocols have been successfully developed which preserve
diagnostic yield at significantly reduced radiation exposure,
and this has been particularly eﬀective in CT scanning of
the thorax [21]. Achieving diagnostic quality low-dose CT
in patients with IBD is particularly challenging as abdominal
and pelvic imaging does not lend itself as well to low
radiation dose scanning as the thorax. CT in the abdomen
and pelvis requires good image contrast to resolve the
pathological changes which occur in the liver, spleen, and
kidneys. The slight increases and decreases in attenuation
value that represent pathology can be obscured by increased
image noise more so than in the thorax, where tissues have
greater inherent contrast due to the large diﬀerence in their
densities [22].
In the past, fixed tube kilovoltage and amperage settings
were used in CT of the abdomen and pelvis; this resulted in
areas such as the mid-abdomen receiving the same exposure
as regions such as the pelvis. This was an ineﬃcient method
of acquisition, and some regions were overirradiated, with-
out any benefit in terms of image quality while other regions
were potentially underexposed, increasing image noise and
reducing image quality [23].
Automatic tube current modulation (ATCM) in CT was a
major development of the last decade [20]. This technology
adjusts tube current during a CT scan depending on X-ray
attenuation in that anatomic location, and tailors the dose
output of the CT tube to patient size and shape. This method
ensures that thicker regions of the body are imaged using
higher tube currents than thinner, less attenuating areas.
Within each imaged section, user-specified noise indices are
chosen, which predict an acceptable level of image noise,
thereby preserving diagnostic quality while minimising radi-
ation exposure [24, 25]. The higher the noise index chosen
by the radiologist, the greater the noise in the CT image
and the lower the radiation dose required to acquire the
image. Studies which investigated the eﬀectiveness of ATCM
for optimising radiation exposure in CT have reported that a
reduction in dose can be achieved in 87% of examinations
using ATCM, with an average tube-current time product
reduction of 32% [24].
Reductions in CT dose often have a negative impact
on the diagnostic quality of the images due to increasing
noise. Noise is a statistical variation in the attenuation values
not reflecting the underlying anatomy which can result in
a lack of clear contrast between two adjacent tissues and
blurring of the anatomic features of the image. As previously
stated, noise can be particularly problematic in the solid
upper abdominal organs such as the liver, spleen, and kidneys
[22]. In patients with IBD where CT findings are most
commonly limited to the small and large bowel, a larger
amount of image noise has been found to be diagnostically
acceptable. In a single series, elevating the noise index to
18–25 yielded a 31–64% reduction in radiation dose while
preserving diagnostic accuracy [26].
At present many noise reduction strategies are being
developed, with varied success, to maintain image quality
while significantly reducing radiation dose. The earliest
strategies included the use of noise reduction filter (NRF)
software applications which are used to postprocess CT
images acquired at significantly reduced radiation dose,
improving their diagnostic quality by reducing image noise
[22, 27]. NRFs were shown to be eﬀective at reducing image
noise, but there is potential for negative impact on diagnostic
quality of images by reduced lesion conspicuity in organs
such as the liver by “over-smoothening” [27].
More promising noise and, therefore, dose reduction
strategies involve improvements in the image reconstruction
process at the time of CT acquisition. The choice of
image reconstruction algorithm is critical to the quality and
appearance of CT images [28].
Although iterative image reconstruction algorithms were
used to generate images in the first commercial clinical
CT scanner [29], filtered back projection (FBP) became
ubiquitous as it is a more rapid and more computationally
eﬃcient method with relatively low mathematical demands
[30]. However, FBP is not well suited to low-dose CT where
data within the image is limited and noise is high [31]; this
has led more recently to renewed research and commercial
interest in refining methods of iterative reconstruction for
reducing noise in images acquired at lower radiation dose.
Methods of iterative reconstruction currently represent the
most exciting dose optimizing developments in CT [32].
Various modifications of iterative reconstruction are being
developed and refined by diﬀerent CTmanufacturers includ-
ing Adaptive Statistical Iterative Reconstruction (ASIR)
(General Electric Healthcare, Milwaukee, WI), Iterative
Reconstruction in Image Space (IRIS) (Siemens Healthcare,
Erlangen, Germany), Adaptive Iterative Dose Reduction
(AIDR) (Toshiba Medical Systems, Tustin, CA), and iDose
(Phillips Healthcare, Best, The Netherlands).
Adaptive statistical iterative reconstruction (ASIR) is
a noise-eﬃcient reconstruction algorithm [33, 34] which
is computationally fast and is proven to result in images
with good low-contrast detail, preserved image quality, and
with typical radiation dose reductions of greater than 30%
[35]. Pilot studies with ASIR found that radiation dose can
successfully be reduced by 50% in CT colonography [36],
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44% in coronary CT angiography [37], and approximately
50% in CT abdomen and pelvis [38] without significantly
aﬀecting image quality.
The next step in optimising image quality in studies
acquired at significantly reduced radiation dose is the
ongoing development of advanced generations of iterative
reconstruction such asModel-Based Iterative Reconstruction
(MBIR), which is being developed by GE Healthcare. MBIR
can incorporate a physical model of the CT system into the
reconstruction process to characterize the data acquisition
process, including noise, beam hardening, and scatter [39].
MBIR oﬀers the potential to further enhance image quality
at even lower radiation doses than ASIR. However, due
to limitations in computing power and reconstruction
technology, model-based iterative approaches have not been
practical for commercial CT scanners until recently, though
studies refining this technology with the aim of introducing
it into clinical practice are now in progress.
Despite emerging advanced reconstruction and process-
ing techniques, it is imperative that dose reduction should
also be achieved by optimizing basic acquisition parameters
during the day to day practice of CT. Human errors in CT
planning have recently been publically highlighted resulting
in gross dose increases [40]. These errors emphasize the
importance of the role of the CT technologist in the careful
planning and design of CT protocols that prioritize dose
optimisation in day to day practice. As an example, scanning
beyond the anatomical limits of the imaging examination
in the context of CT of abdomen and pelvis has been
demonstrated to be common practice, with 97% of cases
having extra images above the diaphragm and 94% having
extra images below the symphysis pubis in a published study
[41]. In the above study, the additional images added little
in terms of extra diagnostic information but added signifi-
cantly to the radiation dose imparted. This study therefore
emphasises that the goal of radiation dose optimisation
requires a multidisciplinary approach and radiologists, CT
technologists, medical physicists, and referring physicians
must be alerted to the fact that attention to detail, and fine
adjustments in practise can have a major impact in this area.
8. Alternatives to CT
In an eﬀort to reduce cumulative radiation exposure to
patients with IBD, many centres currently utilise imaging
techniques such as magnetic resonance imaging (MRI) and
ultrasound, which do not result in exposure to ionising
radiation, to complement or replace CT and barium studies.
In IBD patients, MR enterography oﬀers excellent image
quality, equal to or often better than barium or CT studies,
and, in most clinical settings, represents a realistic alternative
to these studies for examination of the small and large bowel
[42]. Evaluation of small bowel disease has traditionally
been carried out by barium follow-through, which has
an associated eﬀective radiation exposure of 3mSv [10].
When MR studies with oral contrast, performed primarily
for small bowel evaluation, were compared retrospectively
with colonoscopy as standard for large bowel disease iden-
tification, sensitivity of 80% and specificity of 100% for
the detection of colitis were demonstrated, with a positive
predictive value of 1.0 and a negative predictive value of
0.8 [42]. There has been some suggestion that the mucosal
detail seen on MR is inferior to that seen on small bowel
follow-through [43] but MR imaging performed after the
administration of intravenous contrast agents permits the
identification of abnormal mucosal enhancement patterns
which are key indicators of active inflammation. Prospective
comparison of CT and MR enterography and small bowel
follow-through, with optical ileocolonoscopy as reference
standard, showed each modality was equally accurate at
detecting active Crohn’s disease of the small bowel, but the
sensitivity values for CT and MR enterography for the detec-
tion of extraenteric complications were significantly higher
than those for small bowel follow-through [43]. Therefore,
gastrointestinal imaging with MR has the potential to
safely reduce radiation exposure in patients with IBD with
comparable or even superior diagnostic eﬀectiveness to CT.
MRI may prove particularly useful for follow-up imaging,
for the assessment of treatment response, for imaging
of the terminal ileum and caecum following incomplete
colonoscopy, and for imaging of nonacute patients. Residual
intraluminal air, long examination times, increased cost,
and reduced out-of-hours access represent obstacles to the
replacement of CT by MRI in sick patients with acute disease
exacerbations [44]. In the critically ill patient, for a number
of reasons including examination duration and diﬃculty in
monitoring ill patients in MRI scanners, MRI, compared
with CT, is much more diﬃcult to perform.
The intestinal and extraintestinal manifestations of IBD
can also be evaluated using ultrasound, again avoiding
exposure to ionising radiation [44]. Ultrasound is used to
image the small and large bowel with sensitivities of 78–
96%, and 86–100%, respectively, for bowel pathology [44,
45]. While useful in assessment for strictures and fistulae,
and extraintestinal manifestations such as gallstones and
renal calculi, ultrasound appears best able to examine the
terminal ileum and caecum [44]. However, most experts
acknowledge that the use of ultrasound in imaging of IBD
patients is increasingly limited by patient body habitus and,
being inherently operator dependent [44, 45], the feasibility
of using ultrasound to examine the bowel wall for disease
activity varies significantly from centre to centre. The use
of contrast agents with ultrasonography for examination
of the bowel could also be indicated in the followup of
patients with Crohn’s disease as this practice has demon-
strated comparable sensitivity to small bowel enema for the
detection of small bowel lesions, as well as strictures and
prestenotic dilatation [46]. Most radiologists specialising in
gastrointestinal imaging would acknowledge, however, that
ultrasound is unlikely to fully replace barium examinations
or CT in imaging of IBD patients, unlike MR enterography
which could potentially achieve this aim if elimination of
radiation exposure associated with diagnostic imaging was
identified as a major priority and the necessary investment
in MR imaging was made.
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9. Education in Radiation Exposure Associated
with Diagnostic Imaging
When assessed with regard to their knowledge of radiation
exposure and the associated risks, clinicians consistently
perform disappointingly with significant underestimation
of typical radiation exposures associated with diﬀerent
diagnostic imaging studies [47–50]. The European Council
issued the Euratom directive in 1997 and advised integration
of a module in radiation protection, into the curriculum
of medical schools in an eﬀort to raise awareness [51].
Recent evaluation of medical students, undertaken following
curriculum change which included modules in diagnostic
imaging, reassuringly demonstrates an incremental expan-
sion in students’ knowledge of radiation protection with
each year of medical training [52]. In the United States,
the Image Gently campaign was established to increase
public awareness of radiation exposure in children [53, 54].
Along with this, Strauss et al. suggest ten steps to optimise
image quality and lower CT dose in paediatric patients
[55], principles which can largely be applied to imaging
of all patients. A proposed means of raising awareness of
ionising radiation exposure among patients with IBD and
their clinicians, as well as allowing monitoring of cumulative
dose, is the development of a radiation diary [44]. Experts
in the field of radiation dose optimisation have advocated
colour-coding of imaging studies in an eﬀort to highlight
those studies that are associated with exposure to ionising
radiation (red) and those that are not (green) [56].
Selection of the appropriate imaging modality for the
appropriate indication is fundamental. In recent years,
patient care is increasingly adopting a multidisciplinary
approach, therefore collaboration between clinicians and
radiologists is required for creation of agreed imaging pro-
tocols, and patient management and investigation planning
should include consideration of prior cumulative radiation
exposure. Close interaction may help better diﬀerentiate the
clinical indications which justify ionising radiation exposure
with CT from those situations where the use of modalities
such as MR or ultrasound may be more appropriate.
10. Conclusion
There is a broad range of imaging modalities available
for the investigation and management of IBD. Use of CT
has expanded in recent years, with increased availability
and advances in CT hardware and software technology
significantly improving the diagnosis of suspected IBD, the
evaluation of complications, and the response to therapy.
However, concern is mounting worldwide regarding increas-
ing usage of CT and the rapidly growing contribution of
CT scanning to radiation exposure of the entire population
[19]. This issue is particularly important to a number
of patient groups including IBD patients who are “at
risk” for significant cumulative radiation exposure from
diagnostic imaging due to the chronicity of their disease. This
radiation exposure may compound risk for future cancers
in this already predisposed patient population. There is
increasing awareness of the importance of rationalisation
of radiation exposure in IBD patients, to provide the best
quality diagnostic images for the lowest possible dose to the
patient. The optimal strategy for minimization of radiation
exposure in IBD has not yet been determined but requires a
multifaceted collaborative approach. Modification of referral
practices among clinicians, impacted upon by educational
initiatives which highlight the causes and consequences of
diagnostic imaging-related ionizing radiation exposure, has
a large part to play in limiting the number of patients
unnecessarily exposed to a significant radiation burden.
Radiologists, in turn, need to integrate low-dose CT imaging
protocols, which utilise latest technological developments,
into routine practice, particularly in those patients requiring
serial imaging studies, minimising the CT-related dose to
individual patients with each scan performed. The use of
alternative imaging modalities that do not result in radiation
exposure, such as ultrasound and MR, should be encouraged
whenever possible.
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